IP Library › Granted Patent US 7,235,628
Granted Patent B2
US 7,235,628 · App. 11/145,782 · Granted Jun 26, 2007

Analogues of GLP-1

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,628
App. No.
11/145,782
Granted
Jun 26, 2007
Kind
B2
Abstract

The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful thereof comprising said analogues.

Claims (1)

1. A method for treating a disease selected from the group consisting of Type I diabetes and Type II diabetes in a subject in need thereof, said method comprising administering to said subject an effective amount of a compound according to the formula [Aib 8,35 ]hGLP-1(7-36)NH 2 (SEQ ID NO:2), or a pharmaceutically acceptable salt thereof.

Assignments (1)
CHANGE OF NAME Recorded Feb 11, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 022240/0332 →